Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2010

01-01-2010 | Original Article

Reporting on Quality of Life in Randomised Controlled Trials in Gastrointestinal Surgery

Authors: Valerie Bridoux, Grégoire Moutel, Benoit Lefebure, Michel Scotte, Francis Michot, Christian Herve, Jean-Jacques Tuech

Published in: Journal of Gastrointestinal Surgery | Issue 1/2010

Login to get access

Abstract

Background

Although health-related quality of life (HRQOL) has become an important outcome measure in surgical trials, questions still remain about the quality of its reporting. The aim of this study was to evaluate HRQOL assessment methodology of randomised clinical trials concerning gastrointestinal surgery.

Methods

All articles published in the calendar years 2006 and 2007 that purported to assess quality of life as end points or make some conclusion about quality of life were chosen for review from eight general surgical journals and four medical journals. Identified eligible studies were selected and then evaluated on a broad set of predetermined criteria.

Results

Twenty-four published randomised controlled clinical trials (RCTs)s with an HRQOL component were identified. Although most trials exhibited good-quality research, some methodological limitations were identified: Only 21% of the studies gave a rationale for selecting a specific HRQOL measure, 46% of the studies failed to report information about the administration of the HRQOL measure, and 37% did not give details on missing data.

Conclusions

Although it is clear that HRQOL is an important end point in surgical RCTs because the information helps to influence treatment recommendations, a number of methodological shortcomings have to be further addressed in future studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kluivers KB, Riphagen I, Vierhout ME, Brolmann HA, de Vet HC. Systematic review on recovery specific quality-of-life instruments. Surgery 2008;143:206–215.CrossRefPubMed Kluivers KB, Riphagen I, Vierhout ME, Brolmann HA, de Vet HC. Systematic review on recovery specific quality-of-life instruments. Surgery 2008;143:206–215.CrossRefPubMed
2.
go back to reference Schumacher M, Olschewski M, Schulgen G. Assessment of quality of life in clinical trials. Stat Med 1991;10:1915–1930.CrossRefPubMed Schumacher M, Olschewski M, Schulgen G. Assessment of quality of life in clinical trials. Stat Med 1991;10:1915–1930.CrossRefPubMed
4.
go back to reference Kong SX, Gandhi SK. Methodologic assessments of quality of life measures in clinical trials. Ann Pharmacother 1997;31:830–836.PubMed Kong SX, Gandhi SK. Methodologic assessments of quality of life measures in clinical trials. Ann Pharmacother 1997;31:830–836.PubMed
5.
go back to reference Velikova G, Stark D, Selby P. Quality of life instruments in oncology. Eur J Cancer 1999;35:1571–1580.CrossRefPubMed Velikova G, Stark D, Selby P. Quality of life instruments in oncology. Eur J Cancer 1999;35:1571–1580.CrossRefPubMed
6.
go back to reference Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51:1055–1068.CrossRefPubMed Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51:1055–1068.CrossRefPubMed
7.
go back to reference Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995;82:216–222.CrossRefPubMed Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995;82:216–222.CrossRefPubMed
8.
go back to reference Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Cmaj 1986;134:889–895.PubMed Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Cmaj 1986;134:889–895.PubMed
9.
go back to reference Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res 1996;5:496–502.CrossRefPubMed Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res 1996;5:496–502.CrossRefPubMed
10.
go back to reference Avery K, Blazeby JM. Quality of life assessment in surgical oncology trials. World J Surg 2006;30:1163–1172.CrossRefPubMed Avery K, Blazeby JM. Quality of life assessment in surgical oncology trials. World J Surg 2006;30:1163–1172.CrossRefPubMed
11.
go back to reference Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D’Haese S, Zurlo A. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol 2003;21:3502–3511.CrossRefPubMed Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D’Haese S, Zurlo A. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol 2003;21:3502–3511.CrossRefPubMed
12.
go back to reference Efficace F, Bottomley A. Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer 2002;38:1824–1831.CrossRefPubMed Efficace F, Bottomley A. Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer 2002;38:1824–1831.CrossRefPubMed
13.
go back to reference Efficace F, Bottomley A, van Andel G. Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer 2003;97:377–388.CrossRefPubMed Efficace F, Bottomley A, van Andel G. Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer 2003;97:377–388.CrossRefPubMed
14.
go back to reference Bottomley A, Efficace F, Thomas R, Vanvoorden V, Ahmedzai SH. Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials. J Clin Oncol 2003;21:2982–2992.CrossRefPubMed Bottomley A, Efficace F, Thomas R, Vanvoorden V, Ahmedzai SH. Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials. J Clin Oncol 2003;21:2982–2992.CrossRefPubMed
15.
go back to reference Bottomley A, Therasse P. Quality of life in patients undergoing systemic therapy for advanced breast cancer. Lancet Oncol 2002;3:620–628.CrossRefPubMed Bottomley A, Therasse P. Quality of life in patients undergoing systemic therapy for advanced breast cancer. Lancet Oncol 2002;3:620–628.CrossRefPubMed
16.
go back to reference Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality-of-life measurement in randomized clinical trials in breast cancer—taking stock. J Natl Cancer Inst 2003;95:263–281.PubMedCrossRef Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality-of-life measurement in randomized clinical trials in breast cancer—taking stock. J Natl Cancer Inst 2003;95:263–281.PubMedCrossRef
17.
go back to reference Efficace F, Bottomley A, Vanvoorden V, Blazeby JM. Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. Eur J Cancer 2004;40:187–197.CrossRefPubMed Efficace F, Bottomley A, Vanvoorden V, Blazeby JM. Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. Eur J Cancer 2004;40:187–197.CrossRefPubMed
18.
go back to reference Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials—a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008;44:1497–1506.CrossRefPubMed Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials—a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008;44:1497–1506.CrossRefPubMed
19.
go back to reference Gujral S, Avery KN, Blazeby JM. Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials. Support Care Cancer 2008;16:127–132.CrossRefPubMed Gujral S, Avery KN, Blazeby JM. Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials. Support Care Cancer 2008;16:127–132.CrossRefPubMed
20.
go back to reference Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. Jama 2001;285:1992–1995.CrossRefPubMed Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. Jama 2001;285:1992–1995.CrossRefPubMed
21.
go back to reference Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.CrossRefPubMed Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.CrossRefPubMed
22.
go back to reference Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996;12:195–208.CrossRefPubMed Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996;12:195–208.CrossRefPubMed
23.
go back to reference Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. Bmj 2001;323:42–46.CrossRefPubMed Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. Bmj 2001;323:42–46.CrossRefPubMed
24.
go back to reference Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. Jama 1996;276:637–639.CrossRefPubMed Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. Jama 1996;276:637–639.CrossRefPubMed
25.
go back to reference Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191–1194.CrossRefPubMed Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191–1194.CrossRefPubMed
26.
go back to reference Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006;24:3178–3186.CrossRefPubMed Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006;24:3178–3186.CrossRefPubMed
27.
go back to reference Efficace F, Osoba D, Gotay C, Sprangers M, Coens C, Bottomley A. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol 2007;18:775–781.CrossRefPubMed Efficace F, Osoba D, Gotay C, Sprangers M, Coens C, Bottomley A. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol 2007;18:775–781.CrossRefPubMed
28.
go back to reference Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139–144.PubMed Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139–144.PubMed
29.
go back to reference Sprangers MA, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA. Assessing meaningful change in quality of life over time: a users’ guide for clinicians. Mayo Clin Proc 2002;77:561–571.CrossRefPubMed Sprangers MA, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA. Assessing meaningful change in quality of life over time: a users’ guide for clinicians. Mayo Clin Proc 2002;77:561–571.CrossRefPubMed
30.
go back to reference Troxel AB, Fairclough DL, Curran D, Hahn EA. Statistical analysis of quality of life with missing data in cancer clinical trials. Stat Med 1998;17:653–666.CrossRefPubMed Troxel AB, Fairclough DL, Curran D, Hahn EA. Statistical analysis of quality of life with missing data in cancer clinical trials. Stat Med 1998;17:653–666.CrossRefPubMed
31.
go back to reference Bernhard J, Cella DF, Coates AS, Fallowfield L, Ganz PA, Moinpour CM, Mosconi P, Osoba D, Simes J, Hurny C. Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med 1998;17:517–532.CrossRefPubMed Bernhard J, Cella DF, Coates AS, Fallowfield L, Ganz PA, Moinpour CM, Mosconi P, Osoba D, Simes J, Hurny C. Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med 1998;17:517–532.CrossRefPubMed
32.
go back to reference Conroy T, Bleiberg H, Glimelius B. Quality of life in patients with advanced colorectal cancer: what has been learnt? Eur J Cancer 2003;39:287–294.CrossRefPubMed Conroy T, Bleiberg H, Glimelius B. Quality of life in patients with advanced colorectal cancer: what has been learnt? Eur J Cancer 2003;39:287–294.CrossRefPubMed
33.
go back to reference Young T, de Haes H, Curran D. Guidelines for Assessing Quality of Life in EORTC Clinical Trials. The EORTC Quality of Life Group & EORTC Quality of Life Unit, version 2.0. Brussels: EORTC Publications, 2002. Young T, de Haes H, Curran D. Guidelines for Assessing Quality of Life in EORTC Clinical Trials. The EORTC Quality of Life Group & EORTC Quality of Life Unit, version 2.0. Brussels: EORTC Publications, 2002.
34.
go back to reference Osoba D. A taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results. Med Care 2002;40:III31–38.CrossRefPubMed Osoba D. A taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results. Med Care 2002;40:III31–38.CrossRefPubMed
Metadata
Title
Reporting on Quality of Life in Randomised Controlled Trials in Gastrointestinal Surgery
Authors
Valerie Bridoux
Grégoire Moutel
Benoit Lefebure
Michel Scotte
Francis Michot
Christian Herve
Jean-Jacques Tuech
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 1/2010
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-009-1052-y

Other articles of this Issue 1/2010

Journal of Gastrointestinal Surgery 1/2010 Go to the issue